Common Contracts
2 similar Security Agreement contracts by Adhera Therapeutics, Inc., Marina Biotech, Inc.
SECURITY AGREEMENTSecurity Agreement • July 3rd, 2019 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • New York
This SECURITY AGREEMENT (this “Agreement”), dated as of June 28, 2019, among Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), IthenaPharma, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Ithena”), Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“CPI”), and MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research” and, collectively with the Company, Ithena and CPI, the “Grantors” and each, individually, a “Grantor”), the various subscribers (each such person (including any subscriber that becomes a party to this Agreement after the date hereof) a “Purchaser” and collectively the “Purchasers”) signatory to those certain Subscription Agreements of substantially like tenor that the Company entered into, and may enter into after the date hereof, with such subscribers pursuant to which the Company shall issue to such subscribers a secured promissory n
SECURITY AGREEMENTSecurity Agreement • February 13th, 2012 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
This SECURITY AGREEMENT (this “Agreement”), dated as of February 10, 2012, among Marina Biotech, Inc., a Delaware corporation (“MRNA”), Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of MRNA (“CPI”), and MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of MRNA (“Research” and, collectively with MRNA, jointly and severally, the “Grantors” and each, individually, a “Grantor”), the various purchasers (the “Purchasers”) under that certain Note and Warrant Purchase Agreement (as may be amended, restated, supplemented, replaced or otherwise modified from time to time, the “Purchase Agreement), dated as of the date hereof among the Grantors and the Purchasers and Genesis Capital Management, LLC, as agent (the “Agent”) for the Purchasers (the Agent, together with such Purchasers, together with the successors and assigns of each, the “Secured Parties”).
